Acurx Pharmaceuticals LLC (ACXP) — Net Asset Momentum
Acurx Pharmaceuticals LLC (ACXP) recorded a net asset momentum of 756.5% as of December 2025, with net assets of $5.27 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Acurx Pharmaceuticals LLC shareholders equity for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Acurx Pharmaceuticals LLC Net Asset Momentum (2019–2025)
This chart tracks Acurx Pharmaceuticals LLC's year-over-year net asset growth across 7 annual reporting periods from 2019 to 2025. The most recent momentum reading is +756.5%, with net assets of $5.27 Million USD as of December 2025. For live market cap and overall valuation, see Acurx Pharmaceuticals LLC (ACXP) total market value.
Annual Net Asset History for Acurx Pharmaceuticals LLC (2019–2025)
The table below shows the complete annual net asset history for Acurx Pharmaceuticals LLC from 2019 to 2025, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible net worth ratio of Acurx Pharmaceuticals LLC to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $5.27 Million | $7.69 Million | $2.42 Million | ▲ +756.5% |
| 2024 | $615.12K | $3.86 Million | $3.24 Million | ▼ -86.8% |
| 2023 | $4.67 Million | $7.71 Million | $3.04 Million | ▼ -36.2% |
| 2022 | $7.32 Million | $9.38 Million | $2.06 Million | ▼ -41.1% |
| 2021 | $12.41 Million | $13.25 Million | $843.91K | ▲ +359.4% |
| 2020 | $2.70 Million | $3.22 Million | $522.43K | ▲ +229.5% |
| 2019 | $819.85K | $2.53 Million | $1.71 Million | — |